Safety, Feasibility, and Tolerability of Sulforaphane in Children with Chronic Kidney Disease

Summary

This purpose of this study is to investigate potential new therapeutics in pediatric chronic kidney disease (CKD). The specific aims are to identify safe dosing and tolerability of sulforaphane (SFN) supplementation in children with moderate and advanced CKD. Secondary objectives will include preliminary exploration of changes in oxidative and inflammatory biomarkers in response to SFN supplementation in this population.

Timeline

Start

2023-05-15

Primary completion

2025-04-30

Completion

2025-12-31

Drugs

Indications